How do Sunrun Inc. and Zimmer Biomet compare by revenue?

Sunrun Inc. reported revenue of $1.2B in Q4 FY2025, while Zimmer Biomet reported $2.1B in Q1 FY2026. Zimmer Biomet is 1.8× larger by last-quarter revenue.

Which is growing revenue faster, Sunrun Inc. or Zimmer Biomet?

Sunrun Inc.'s latest revenue grew 123.5% year-over-year, versus 9.3% for Zimmer Biomet. Sunrun Inc. is growing faster on a YoY basis.

Which has a higher net margin, Sunrun Inc. or Zimmer Biomet?

Sunrun Inc.'s net margin is 8.9% vs Zimmer Biomet's 11.4%. Zimmer Biomet has the higher bottom-line margin.

What is the 2-year revenue CAGR for Sunrun Inc. vs Zimmer Biomet?

Over the trailing 8 quarters, Sunrun Inc. compounded revenue at roughly 59.0% per year, versus 3.7% for Zimmer Biomet. Sunrun Inc. has the faster medium-term growth trajectory.

Where does this RUN vs ZBH data come from?

All figures are parsed directly from SEC EDGAR 10-Q / 10-K / 20-F / 6-K filings (for US-listed issuers) or EDINET filings (for Japanese issuers), then normalised into a common schema. Numbers update automatically as new filings are released.

vs

Side-by-side financial comparison of Sunrun Inc. (RUN) and Zimmer Biomet (ZBH). Click either name above to swap in a different company.

Zimmer Biomet is the larger business by last-quarter revenue ($2.1B vs $1.2B, roughly 1.8× Sunrun Inc.). Zimmer Biomet runs the higher net margin — 11.4% vs 8.9%, a 2.5% gap on every dollar of revenue. On growth, Sunrun Inc. posted the faster year-over-year revenue change (123.5% vs 9.3%). Over the past eight quarters, Sunrun Inc.'s revenue compounded faster (59.0% CAGR vs 3.7%).

Sunrun Inc.RUNEarnings & Financial Report

Nasdaq · Industrials · Miscellaneous Electrical Machinery, Equipment & Supplies

Sunrun Inc. is an American provider of photovoltaic systems and battery energy storage products, primarily for residential customers. The company was established in 2007 and is headquartered in San Francisco, California.

Zimmer BiometZBHEarnings & Financial Report

NYSE · Health Care · Orthopedic, Prosthetic & Surgical Appliances & Supplies

Zimmer Biomet Holdings, Inc. is a publicly traded American medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster.

RUN vs ZBH — Head-to-Head

Bigger by revenue

ZBH

1.8× larger

$2.1B

$1.2B

Growing faster (revenue YoY)

RUN

+114.2% gap

123.5%

9.3%

Higher net margin

ZBH

2.5% more per $

11.4%

8.9%

Faster 2-yr revenue CAGR

RUN

Annualised

59.0%

3.7%

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric	RUN	ZBH
Revenue	$1.2B	$2.1B
Net Profit	$103.6M	$238.3M
Gross Margin	—	64.6%
Operating Margin	8.4%	17.9%
Net Margin	8.9%	11.4%
Revenue YoY	123.5%	9.3%
Net Profit YoY	103.7%	30.5%
EPS (diluted)	$0.38	$1.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue

RUN

ZBH

Q1 26	—	$2.1B
Q4 25	$1.2B	$2.2B
Q3 25	$724.6M	$2.0B
Q2 25	$569.3M	$2.1B
Q1 25	$504.3M	$1.9B
Q4 24	$518.5M	$2.0B
Q3 24	$537.2M	$1.8B
Q2 24	$523.9M	$1.9B

Net Profit

RUN

ZBH

Q1 26	—	$238.3M
Q4 25	$103.6M	$139.4M
Q3 25	$16.6M	$230.9M
Q2 25	$279.8M	$152.8M
Q1 25	$50.0M	$182.0M
Q4 24	$-2.8B	$239.5M
Q3 24	$-83.8M	$249.1M
Q2 24	$139.1M	$242.8M

Gross Margin

RUN

ZBH

Q1 26	—	64.6%
Q4 25	—	64.7%
Q3 25	—	72.1%
Q2 25	—	71.5%
Q1 25	—	71.2%
Q4 24	—	71.0%
Q3 24	—	70.5%
Q2 24	—	71.5%

Operating Margin

RUN

ZBH

Q1 26	—	17.9%
Q4 25	8.4%	6.9%
Q3 25	0.5%	17.6%
Q2 25	-19.7%	14.4%
Q1 25	-22.8%	15.3%
Q4 24	-628.0%	19.2%
Q3 24	-23.8%	15.3%
Q2 24	-24.4%	18.1%

Net Margin

RUN

ZBH

Q1 26	—	11.4%
Q4 25	8.9%	6.2%
Q3 25	2.3%	11.5%
Q2 25	49.1%	7.4%
Q1 25	9.9%	9.5%
Q4 24	-542.7%	11.8%
Q3 24	-15.6%	13.7%
Q2 24	26.5%	12.5%

EPS (diluted)

RUN

ZBH

Q1 26	—	$1.22
Q4 25	$0.38	$0.71
Q3 25	$0.06	$1.16
Q2 25	$1.07	$0.77
Q1 25	$0.20	$0.91
Q4 24	$-12.59	$1.18
Q3 24	$-0.37	$1.23
Q2 24	$0.55	$1.18

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric	RUN	ZBH
Cash + ST InvestmentsLiquidity on hand	—	$424.2M
Total DebtLower is stronger	$14.7B	$7.5B
Stockholders' EquityBook value	$3.1B	$12.7B
Total Assets	$22.6B	$22.7B
Debt / EquityLower = less leverage	4.69×	0.59×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments

RUN

ZBH

Q1 26	—	$424.2M
Q4 25	—	$591.9M
Q3 25	—	$1.3B
Q2 25	—	$556.9M
Q1 25	—	$1.4B
Q4 24	—	$525.5M
Q3 24	—	$569.0M
Q2 24	—	$420.1M

Total Debt

RUN

ZBH

Q1 26	—	$7.5B
Q4 25	$14.7B	—
Q3 25	$14.6B	—
Q2 25	$14.0B	—
Q1 25	$13.6B	—
Q4 24	$12.9B	—
Q3 24	$12.5B	—
Q2 24	$12.0B	—

Stockholders' Equity

RUN

ZBH

Q1 26	—	$12.7B
Q4 25	$3.1B	$12.7B
Q3 25	$3.0B	$12.8B
Q2 25	$2.9B	$12.5B
Q1 25	$2.6B	$12.4B
Q4 24	$2.6B	$12.5B
Q3 24	$5.3B	$12.4B
Q2 24	$5.4B	$12.7B

Total Assets

RUN

ZBH

Q1 26	—	$22.7B
Q4 25	$22.6B	$23.1B
Q3 25	$22.2B	$23.5B
Q2 25	$21.2B	$22.9B
Q1 25	$20.4B	$22.2B
Q4 24	$19.9B	$21.4B
Q3 24	$22.1B	$21.7B
Q2 24	$21.4B	$21.5B

Debt / Equity

RUN

ZBH

Q1 26	—	0.59×
Q4 25	4.69×	—
Q3 25	4.90×	—
Q2 25	4.80×	—
Q1 25	5.19×	—
Q4 24	5.05×	—
Q3 24	2.36×	—
Q2 24	2.23×	—

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric	RUN	ZBH
Operating Cash FlowLast quarter	$96.9M	$359.4M
Free Cash FlowOCF − Capex	—	$245.9M
FCF MarginFCF / Revenue	—	11.8%
Capex IntensityCapex / Revenue	—	—
Cash ConversionOCF / Net Profit	0.94×	1.51×
TTM Free Cash FlowTrailing 4 quarters	—	$1.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow

RUN

ZBH

Q1 26	—	$359.4M
Q4 25	$96.9M	$517.4M
Q3 25	$-121.5M	$418.7M
Q2 25	$-292.7M	$378.2M
Q1 25	$-104.2M	$382.8M
Q4 24	$-258.4M	$506.3M
Q3 24	$-156.2M	$395.7M
Q2 24	$-208.5M	$369.4M